Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Gerretsen

Showing results (141-150 of 196) with videos related to

Pageof 20
Sort By:
NPJ Schizophrenia|May 1, 2019
Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrityPhilip Gerretsen, Tarek K Rajji, Parita Shah, et al.
Biological Psychiatry|November 4, 2018
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy StudyYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Psychiatry Research|July 7, 2024
Effect of personality traits, psychological resilience and life adversities on lifetime violence trajectories: A novel classification model in schizophreniaGeorge Nader, Muneefah Qureshi, Zanib Chaudhary, et al.
Acta Psychiatrica Scandinavica|June 21, 2022
Metformin for the prevention of clozapine-induced weight gain: A retrospective naturalistic cohort studyNicolette Stogios, Kateryna Maksyutynska, Janani Navagnanavel, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive ImpairmentJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Schizophrenia Bulletin|May 15, 2024
Evaluation of the Glymphatic System in Schizophrenia Spectrum Disorder Using Proton Magnetic Resonance Spectroscopy Measurement of Brain Macromolecule and Diffusion Tensor Image Analysis Along the Perivascular Space IndexAli Abdolizadeh, Edgardo Torres-Carmona, Yasaman Kambari, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disordersJulia Kim, Eric Plitman, Yusuke Iwata, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2017
The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief ReportJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Journal of Affective Disorders|January 2, 2023
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II StudyJianmeng Song, Benoit H Mulsant, Marcos Sanches, et al.
Psychoneuroendocrinology|April 22, 2017
Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioningFernando Caravaggio, Philip Gerretsen, Wanna Mar, et al.
Pageof 20

Showing results (141-150 of 196) with videos related to

Sort By:
Pageof 20
NPJ Schizophrenia|May 1, 2019
Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrityPhilip Gerretsen, Tarek K Rajji, Parita Shah, et al.
Biological Psychiatry|November 4, 2018
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy StudyYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Psychiatry Research|July 7, 2024
Effect of personality traits, psychological resilience and life adversities on lifetime violence trajectories: A novel classification model in schizophreniaGeorge Nader, Muneefah Qureshi, Zanib Chaudhary, et al.
Acta Psychiatrica Scandinavica|June 21, 2022
Metformin for the prevention of clozapine-induced weight gain: A retrospective naturalistic cohort studyNicolette Stogios, Kateryna Maksyutynska, Janani Navagnanavel, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive ImpairmentJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Schizophrenia Bulletin|May 15, 2024
Evaluation of the Glymphatic System in Schizophrenia Spectrum Disorder Using Proton Magnetic Resonance Spectroscopy Measurement of Brain Macromolecule and Diffusion Tensor Image Analysis Along the Perivascular Space IndexAli Abdolizadeh, Edgardo Torres-Carmona, Yasaman Kambari, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disordersJulia Kim, Eric Plitman, Yusuke Iwata, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2017
The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief ReportJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Journal of Affective Disorders|January 2, 2023
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II StudyJianmeng Song, Benoit H Mulsant, Marcos Sanches, et al.
Psychoneuroendocrinology|April 22, 2017
Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioningFernando Caravaggio, Philip Gerretsen, Wanna Mar, et al.
Pageof 20